glp -1 drugs New GLP-1 Guidelines for Type 2 Diabetes in 2025 The GLP-1 Revolution: From Diabetes
Description
placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal-F1) Diabet Med
Maintaining peptide stability during preparation is also important for obtaining accurate analytical results
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
MAUD-obesity trial: Patients with obesity, no T2D, and markers of more severe AUD, comparing newer GLP-1 RAs to MAUD
As cheaper versions become widely available, adherence and continuity of care could become major concerns
While this could reflect healthier self-regulation, the authors say that in some cases, increased restraint may be linked to disordered eating behaviors
